Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Vitamin D Supplements May Provide Inexpensive and Effective Boost Against TB

By Biotechdaily staff writers
Posted on 22 May 2007
Scientists have shown that a single 2.5 mg dose of vitamin D may be enough to trigger the immune system to fight against tuberculosis (TB) and similar bacteria for at least six weeks. More...


These findings came from a study that identified an extremely high incidence of vitamin D deficiency among those communities in London (UK) most at risk from the disease, which kills around two million people each year.

Whereas a diet of oily fish can provide some vitamin D, the main source of the body's vitamin D comes from exposing the skin to sunlight. In Britain, however, the amount of sunlight is usually not enough to generate vitamin D in the skin between October and April, and much of the population becomes deficient during the winter and spring.

Researchers from Queen Mary's School of Medicine and Dentistry (London; UK) and the Wellcome Trust Centre for Research in Clinical Tropical Medicine at Imperial College London (UK) studied patients at Newham University Hospital and Northwick Park Hospital (both in London, UK) who had been exposed to TB. They found that over 90% of such patients had a vitamin D deficiency.

Vitamin D was used to treat TB in the pre-antibiotic era, when special sanatoria were constructed in sunny locations, such as the Swiss Alps. But until now, no study has assessed the effect of vitamin D supplementation on immunity to mycobacteria, the family of bacteria that cause TB.

The researchers performed a randomized control trial on a group of volunteers who were given either a 2.5 mg vitamin D supplement or a placebo. Samples of the volunteers' blood were then tested in Dr. Robert Wilkinson's Wellcome Trust-funded laboratory at Imperial College, to see whether the supplement affected the immune system's ability to resist infection by mycobacteria.

"We found that a single large dose of vitamin D was sufficient to enhance a person's immunity to the bacteria,” stated Dr. Adrian Martineau, from the division of medicine at Imperial College London, who coordinated the study. "This is very significant given the high levels of vitamin D deficiency in people at the highest risk of TB infection, and shows that a simple, cheap supplement could make a significant impact on the health of people most at risk from the disease.”

According to the UK Health Protection Agency, the incidence of TB in the United Kingdom is increasing, with about 8,000 new cases a year. Cases in the United Kingdom are predominantly confined to the major cities and approximately 40% of all cases are in London. TB is also a major global problem: an estimated one-third of the world's population--nearly two billion people--are infected. Nine million people per year develop the active disease worldwide, which kills two million each year.

"Most cases of TB in London arise from people who have already become infected with the bacteria but in whom it lies latent,” noted Prof. Chris Griffiths from Queen Mary's School of Medicine and Dentistry. "Our results indicate that vitamin D supplementation may prevent reactivation of latent TB. Identifying people with latent TB and providing supplements could be an important strategy for tackling the disease.”

The treatment is both very inexpensive and safe. Vitamin D supplements could be prescribed for patients with or at risk of latent TB through GP surgeries. Dr. Martineau pointed out, "Our work adds to the growing evidence that vitamin D may have a wide range of important health benefits, including preventing falls and fractures and reducing risk of cancer and diabetes, as well as boosting the immune system against infection. Population-wide supplementation needs to be considered by public health planners. Milk and orange juice could be fortified with vitamin D, as in the US and Canada. At present, only margarine is supplemented in the UK, and recent studies show that this is not an effective way to prevent vitamin D deficiency.”


Related Links:
Queen Mary's School of Medicine and Dentistry
Imperial College London

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.